Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients (pts) with advanced NSCLC: Preliminary results of a phase II trial.

被引：0
|
作者：
Hanna, NH
Estes, D
Cress, A
Sidor, C
机构：
[1] Entremed, Rockville, MD USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7105
引用
收藏
页码：642S / 642S
页数：1
相关论文
共 50 条
  • [21] THE COMBINATION CHEMOTHERAPY OF CARBOPLATIN AND WEEKLY PACLITAXEL PLUS BEVACIZUMAB IN PATIENTS WITH ADVANCED NSCLC
    Kitaguchi, S.
    Kagawa, M.
    Yamaguchi, K.
    Watanabe, M.
    Ogawa, T.
    Furonaka, O.
    Sugahara, F.
    Egawa, H.
    ANNALS OF ONCOLOGY, 2013, 24
  • [22] Gemcitabine and carboplatin combination in advanced solid tumors: A phase I trial.
    Tassinari, D
    Pasini, G
    Arcangeli, V
    Panzini, I
    Drudi, G
    Gianni, L
    Oliverio, G
    Sartori, S
    Fochessati, F
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
  • [23] A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma
    Yeo, W
    Leung, TWT
    Chan, ATC
    Chiu, SKW
    Yu, P
    Mok, TSK
    Johnson, PJ
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (13) : 2027 - 2031
  • [24] Lurbinectedin (LUR) in combination with Irinotecan (IRI) in patients (pts) with advanced solid tumors: Updated results from a phase Ib-II trial.
    Ponce Aix, Santiago
    Michael Cote, Gregory
    Falcon Gonzalez, Alejandro
    Manuel Sepulveda, Juan
    Jimenez Aguilar, Elizabeth
    Sanchez-Simon, Inmaculada
    Jose Flor, Maria
    Nunez, Rafael
    Maria Gonzalez, Eva
    Insa, Monica
    Siguero, Mariano
    Cullell-Young, Martin
    Maria Kahatt, Carmen
    Hassan Zeaiter, Ali
    Paz-Ares, Luis G.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] SUNITINIB IN COMBINATION WITH CARBOPLATIN (C) PLUS PACLITAXEL (P) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS (STS): PHASE I STUDY RESULTS
    Heath, E. I.
    Blumenschein, G. R.
    Cohen, R. B.
    LoRusso, P. Mucci
    LoConte, N.
    Kim, S. T.
    Chao, R.
    Wilding, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [26] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [27] Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder
    Smith, David C.
    Mackler, Niklas J.
    Dunn, Rodney L.
    Hussain, Maha
    Wood, David
    Lee, Cheryl T.
    Sanda, Martin
    Vaishampayan, Ulka
    Petrylak, Daniel P.
    Quinn, David I.
    Beekman, Kathleen
    Montie, James E.
    JOURNAL OF UROLOGY, 2008, 180 (06): : 2384 - 2388
  • [28] Everolimus in combination with paclitaxel and carboplatin in patients with advanced melanoma: A phase II trial of the Sarah Cannon Research Institute (SCRI)
    Hauke, Ralph J.
    Infante, Jeffrey R.
    Shih, Kent C.
    Rubin, Mark S.
    Arrowsmith, Edward
    Whorf, Robert C.
    Hainsworth, John D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Phase Ib study of recombinant human (rh)Apo2L/TRAIL in combination with paclitaxel, carboplatin, and bevacizumab (PCB) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Soria, J.
    Smit, E. F.
    Khayat, D.
    Besse, B.
    Burton, J.
    Yang, X.
    Hsu, M.
    Braun, A.
    Reese, D.
    Blackhall, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: Preliminary results
    Palackdharry, CS
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S108 - S112
12345